# Short-course Radiotherapy Combined With Chemotherapy and Pd-1 Inhibitor for Locally Advanced Colon Cancer(TORCH-C)

> **NCT05732493** · PHASE2 · UNKNOWN · sponsor: **Fudan University** · enrollment: 120 (estimated)

## Conditions studied

- Locally Advanced Colon Cancer

## Interventions

- **DRUG:** Serplulimab
- **RADIATION:** short-term radiotherapy
- **DRUG:** Oxaliplatin
- **DRUG:** Capecitabine

## Key facts

- **NCT ID:** NCT05732493
- **Lead sponsor:** Fudan University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-03-01
- **Primary completion:** 2023-12-31
- **Final completion:** 2024-12-31
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2023-02-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05732493

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05732493, "Short-course Radiotherapy Combined With Chemotherapy and Pd-1 Inhibitor for Locally Advanced Colon Cancer(TORCH-C)". Retrieved via AI Analytics 2026-09-21 from https://api.ai-analytics.org/clinical/NCT05732493. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*